Abstract | OBJECTIVE: METHODS: Consecutive 21 patients with status migrainosus were received intra-venous chlorpromazine (maximum 25mg) with fluid treatment and their results were documented. RESULTS: CONCLUSIONS:
|
Authors | Uygar Utku, Mustafa Gokce, Elif Muruvvet Benli, Aytaç Dinc, Deniz Tuncel |
Journal | Clinical neurology and neurosurgery
(Clin Neurol Neurosurg)
Vol. 119
Pg. 4-5
(Apr 2014)
ISSN: 1872-6968 [Electronic] Netherlands |
PMID | 24635917
(Publication Type: Journal Article)
|
Copyright | Copyright © 2014 Elsevier B.V. All rights reserved. |
Chemical References |
- Antiemetics
- Chlorpromazine
|
Topics |
- Administration, Intravenous
- Adult
- Antiemetics
(therapeutic use)
- Chlorpromazine
(therapeutic use)
- Cohort Studies
- Female
- Fluid Therapy
(methods)
- Humans
- Male
- Migraine Disorders
(therapy)
- Prospective Studies
- Treatment Outcome
|